aluates Reports

$ 0.0

Automative

Global Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: March 2025

Report Code: QYRE-Auto-33X5535

Global Vaccine Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-33X5535

Report

March 2025

Pages:120

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

BioNTech

Boehringer Ingelheim

CCBIO

CSL Limited

CureVac

Elanco

GSK

Hulan Bio

Indian Immunologicals

Merck

Minhai Biotechnology

Mitsubishi Tanabe Pharma

Moderna Therapeutics

Mylan NV

Plumbline Life Sciences

Sanofi

Translate Bio

Walvax Biotechnology

Wuhan Institute of Biological Products

Zoties

Vaccine Sales Market

The global Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

The North America Vaccine market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key players of Vaccine include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Vaccine Sales Market Report

Report Metric	Details
Report Name	Vaccine Sales Market
By Type: (Dominant Segment vs High-Margin Innovation)	Varicella Vaccine Influenza Vaccine Polio Vaccine Hepatitis A Vaccine Rabies Vaccine BCG Vaccine Hepatitis B Pertussis, Diphtheria, Tetanus Pneumococcal Others
By Application: (Core Demand Driver vs Emerging Opportunity)	For Adult For Child
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, Merck, Minhai Biotechnology, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Mylan, Plumbline Life Sciences, Sanofi, Translate Bio, Walvax Biotechnology, Wuhan Institute of Biological Products, Zoties
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Vaccine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Influenza Vaccine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., For Child in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Vaccine value chain, addressing:

FAQ for this report

Who are the main players in the Vaccine Sales Market report?

Ans: The main players in the Vaccine Sales Market are AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, Merck, Minhai Biotechnology, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Mylan, Plumbline Life Sciences, Sanofi, Translate Bio, Walvax Biotechnology, Wuhan Institute of Biological Products, Zoties

What are the Application segmentation covered in the Vaccine Sales Market report?

Ans: The Applications covered in the Vaccine Sales Market report are For Adult, For Child

What are the Type segmentation covered in the Vaccine Sales Market report?

Ans: The Types covered in the Vaccine Sales Market report are Varicella Vaccine, Influenza Vaccine, Polio Vaccine, Hepatitis A Vaccine, Rabies Vaccine, BCG Vaccine, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Others

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Varicella Vaccine

1.2.3 Influenza Vaccine

1.2.4 Polio Vaccine

1.2.5 Hepatitis A Vaccine

1.2.6 Rabies Vaccine

1.2.7 BCG Vaccine

1.2.8 Hepatitis B

1.2.9 Pertussis, Diphtheria, Tetanus

1.2.10 Pneumococcal

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 For Adult

1.3.3 For Child

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Vaccine Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Vaccine Revenue Market Share by Region (2020-2025)

2.4 Global Vaccine Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Vaccine Market Size and Prospective (2020-2031)

2.5.2 Europe Vaccine Market Size and Prospective (2020-2031)

2.5.3 China Vaccine Market Size and Prospective (2020-2031)

2.5.4 Japan Vaccine Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Vaccine Historic Market Size by Type (2020-2025)

3.2 Global Vaccine Forecasted Market Size by Type (2026-2031)

3.3 Different Types Vaccine Representative Players

4 Breakdown Data by Application

4.1 Global Vaccine Historic Market Size by Application (2020-2025)

4.2 Global Vaccine Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Vaccine Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Vaccine Players by Revenue (2020-2025)

5.1.2 Global Vaccine Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Vaccine Revenue

5.4 Global Vaccine Market Concentration Analysis

5.4.1 Global Vaccine Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Vaccine Revenue in 2024

5.5 Global Key Players of Vaccine Head office and Area Served

5.6 Global Key Players of Vaccine, Product and Application

5.7 Global Key Players of Vaccine, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Vaccine Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Vaccine Market Size by Type (2020-2025)

6.1.2.2 North America Vaccine Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Vaccine Market Size by Application (2020-2025)

6.1.3.2 North America Vaccine Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Vaccine Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Vaccine Market Size by Type (2020-2025)

6.2.2.2 Europe Vaccine Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Vaccine Market Size by Application (2020-2025)

6.2.3.2 Europe Vaccine Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Vaccine Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Vaccine Market Size by Type (2020-2025)

6.3.2.2 China Vaccine Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Vaccine Market Size by Application (2020-2025)

6.3.3.2 China Vaccine Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Vaccine Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Vaccine Market Size by Type (2020-2025)

6.4.2.2 Japan Vaccine Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Vaccine Market Size by Application (2020-2025)

6.4.3.2 Japan Vaccine Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

7 Key Players Profiles

7.1 AstraZeneca

7.1.1 AstraZeneca Company Details

7.1.2 AstraZeneca Business Overview

7.1.3 AstraZeneca Vaccine Introduction

7.1.4 AstraZeneca Revenue in Vaccine Business (2020-2025)

7.1.5 AstraZeneca Recent Development

7.2 BioNTech

7.2.1 BioNTech Company Details

7.2.2 BioNTech Business Overview

7.2.3 BioNTech Vaccine Introduction

7.2.4 BioNTech Revenue in Vaccine Business (2020-2025)

7.2.5 BioNTech Recent Development

7.3 Boehringer-Ingelheim

7.3.1 Boehringer-Ingelheim Company Details

7.3.2 Boehringer-Ingelheim Business Overview

7.3.3 Boehringer-Ingelheim Vaccine Introduction

7.3.4 Boehringer-Ingelheim Revenue in Vaccine Business (2020-2025)

7.3.5 Boehringer-Ingelheim Recent Development

7.4 CCBIO

7.4.1 CCBIO Company Details

7.4.2 CCBIO Business Overview

7.4.3 CCBIO Vaccine Introduction

7.4.4 CCBIO Revenue in Vaccine Business (2020-2025)

7.4.5 CCBIO Recent Development

7.5 CSL

7.5.1 CSL Company Details

7.5.2 CSL Business Overview

7.5.3 CSL Vaccine Introduction

7.5.4 CSL Revenue in Vaccine Business (2020-2025)

7.5.5 CSL Recent Development

7.6 CureVac

7.6.1 CureVac Company Details

7.6.2 CureVac Business Overview

7.6.3 CureVac Vaccine Introduction

7.6.4 CureVac Revenue in Vaccine Business (2020-2025)

7.6.5 CureVac Recent Development

7.7 Elanco

7.7.1 Elanco Company Details

7.7.2 Elanco Business Overview

7.7.3 Elanco Vaccine Introduction

7.7.4 Elanco Revenue in Vaccine Business (2020-2025)

7.7.5 Elanco Recent Development

7.8 GSK

7.8.1 GSK Company Details

7.8.2 GSK Business Overview

7.8.3 GSK Vaccine Introduction

7.8.4 GSK Revenue in Vaccine Business (2020-2025)

7.8.5 GSK Recent Development

7.9 Hulan Bio

7.9.1 Hulan Bio Company Details

7.9.2 Hulan Bio Business Overview

7.9.3 Hulan Bio Vaccine Introduction

7.9.4 Hulan Bio Revenue in Vaccine Business (2020-2025)

7.9.5 Hulan Bio Recent Development

7.10 Indian Immunologicals

7.10.1 Indian Immunologicals Company Details

7.10.2 Indian Immunologicals Business Overview

7.10.3 Indian Immunologicals Vaccine Introduction

7.10.4 Indian Immunologicals Revenue in Vaccine Business (2020-2025)

7.10.5 Indian Immunologicals Recent Development

7.11 Merck

7.11.1 Merck Company Details

7.11.2 Merck Business Overview

7.11.3 Merck Vaccine Introduction

7.11.4 Merck Revenue in Vaccine Business (2020-2025)

7.11.5 Merck Recent Development

7.12 Minhai Biotechnology

7.12.1 Minhai Biotechnology Company Details

7.12.2 Minhai Biotechnology Business Overview

7.12.3 Minhai Biotechnology Vaccine Introduction

7.12.4 Minhai Biotechnology Revenue in Vaccine Business (2020-2025)

7.12.5 Minhai Biotechnology Recent Development

7.13 Mitsubishi Tanabe Pharma

7.13.1 Mitsubishi Tanabe Pharma Company Details

7.13.2 Mitsubishi Tanabe Pharma Business Overview

7.13.3 Mitsubishi Tanabe Pharma Vaccine Introduction

7.13.4 Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2020-2025)

7.13.5 Mitsubishi Tanabe Pharma Recent Development

7.14 Moderna Therapeutics

7.14.1 Moderna Therapeutics Company Details

7.14.2 Moderna Therapeutics Business Overview

7.14.3 Moderna Therapeutics Vaccine Introduction

7.14.4 Moderna Therapeutics Revenue in Vaccine Business (2020-2025)

7.14.5 Moderna Therapeutics Recent Development

7.15 Mylan

7.15.1 Mylan Company Details

7.15.2 Mylan Business Overview

7.15.3 Mylan Vaccine Introduction

7.15.4 Mylan Revenue in Vaccine Business (2020-2025)

7.15.5 Mylan Recent Development

7.16 Plumbline Life Sciences

7.16.1 Plumbline Life Sciences Company Details

7.16.2 Plumbline Life Sciences Business Overview

7.16.3 Plumbline Life Sciences Vaccine Introduction

7.16.4 Plumbline Life Sciences Revenue in Vaccine Business (2020-2025)

7.16.5 Plumbline Life Sciences Recent Development

7.17 Sanofi

7.17.1 Sanofi Company Details

7.17.2 Sanofi Business Overview

7.17.3 Sanofi Vaccine Introduction

7.17.4 Sanofi Revenue in Vaccine Business (2020-2025)

7.17.5 Sanofi Recent Development

7.18 Translate Bio

7.18.1 Translate Bio Company Details

7.18.2 Translate Bio Business Overview

7.18.3 Translate Bio Vaccine Introduction

7.18.4 Translate Bio Revenue in Vaccine Business (2020-2025)

7.18.5 Translate Bio Recent Development

7.19 Walvax Biotechnology

7.19.1 Walvax Biotechnology Company Details

7.19.2 Walvax Biotechnology Business Overview

7.19.3 Walvax Biotechnology Vaccine Introduction

7.19.4 Walvax Biotechnology Revenue in Vaccine Business (2020-2025)

7.19.5 Walvax Biotechnology Recent Development

7.20 Wuhan Institute of Biological Products

7.20.1 Wuhan Institute of Biological Products Company Details

7.20.2 Wuhan Institute of Biological Products Business Overview

7.20.3 Wuhan Institute of Biological Products Vaccine Introduction

7.20.4 Wuhan Institute of Biological Products Revenue in Vaccine Business (2020-2025)

7.20.5 Wuhan Institute of Biological Products Recent Development

7.21 Zoties

7.21.1 Zoties Company Details

7.21.2 Zoties Business Overview

7.21.3 Zoties Vaccine Introduction

7.21.4 Zoties Revenue in Vaccine Business (2020-2025)

7.21.5 Zoties Recent Development

8 Vaccine Market Dynamics

8.1 Vaccine Industry Trends

8.2 Vaccine Market Drivers

8.3 Vaccine Market Challenges

8.4 Vaccine Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

BioNTech

Boehringer Ingelheim

CCBIO

CSL Limited

CureVac

Elanco

GSK

Hulan Bio

Indian Immunologicals

Merck

Minhai Biotechnology

Mitsubishi Tanabe Pharma

Moderna Therapeutics

Mylan NV

Plumbline Life Sciences

Sanofi

Translate Bio

Walvax Biotechnology

Wuhan Institute of Biological Products

Zoties

List of Tables

Table 1. Global Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Vaccine Revenue Share by Region (2020-2025)

Table 6. Global Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Vaccine Revenue Share Forecast by Region (2026-2031)

Table 8. Global Vaccine Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Vaccine Revenue Market Share by Type (2020-2025)

Table 10. Global Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Vaccine Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Vaccine Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Vaccine Revenue Market Share by Application (2020-2025)

Table 15. Global Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Vaccine Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Vaccine Application

Table 18. Global Vaccine Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Vaccine Market Share by Players (2020-2025)

Table 20. Global Top Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine as of 2024)

Table 21. Ranking of Global Top Vaccine Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Vaccine Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Vaccine, Headquarters and Area Served

Table 24. Global Key Players of Vaccine, Product and Application

Table 25. Global Key Players of Vaccine, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Vaccine Revenue Market Share by Company (2020-2025)

Table 29. North America Vaccine Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Vaccine Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Vaccine Revenue Market Share by Company (2020-2025)

Table 33. Europe Vaccine Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Vaccine Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Vaccine Revenue Market Share by Company (2020-2025)

Table 37. China Vaccine Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Vaccine Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Vaccine Revenue Market Share by Company (2020-2025)

Table 41. Japan Vaccine Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Vaccine Market Size by Application (2020-2025) & (US$ Million)

Table 43. AstraZeneca Company Details

Table 44. AstraZeneca Business Overview

Table 45. AstraZeneca Vaccine Product

Table 46. AstraZeneca Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 47. AstraZeneca Recent Development

Table 48. BioNTech Company Details

Table 49. BioNTech Business Overview

Table 50. BioNTech Vaccine Product

Table 51. BioNTech Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 52. BioNTech Recent Development

Table 53. Boehringer-Ingelheim Company Details

Table 54. Boehringer-Ingelheim Business Overview

Table 55. Boehringer-Ingelheim Vaccine Product

Table 56. Boehringer-Ingelheim Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 57. Boehringer-Ingelheim Recent Development

Table 58. CCBIO Company Details

Table 59. CCBIO Business Overview

Table 60. CCBIO Vaccine Product

Table 61. CCBIO Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 62. CCBIO Recent Development

Table 63. CSL Company Details

Table 64. CSL Business Overview

Table 65. CSL Vaccine Product

Table 66. CSL Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 67. CSL Recent Development

Table 68. CureVac Company Details

Table 69. CureVac Business Overview

Table 70. CureVac Vaccine Product

Table 71. CureVac Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 72. CureVac Recent Development

Table 73. Elanco Company Details

Table 74. Elanco Business Overview

Table 75. Elanco Vaccine Product

Table 76. Elanco Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 77. Elanco Recent Development

Table 78. GSK Company Details

Table 79. GSK Business Overview

Table 80. GSK Vaccine Product

Table 81. GSK Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 82. GSK Recent Development

Table 83. Hulan Bio Company Details

Table 84. Hulan Bio Business Overview

Table 85. Hulan Bio Vaccine Product

Table 86. Hulan Bio Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 87. Hulan Bio Recent Development

Table 88. Indian Immunologicals Company Details

Table 89. Indian Immunologicals Business Overview

Table 90. Indian Immunologicals Vaccine Product

Table 91. Indian Immunologicals Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 92. Indian Immunologicals Recent Development

Table 93. Merck Company Details

Table 94. Merck Business Overview

Table 95. Merck Vaccine Product

Table 96. Merck Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 97. Merck Recent Development

Table 98. Minhai Biotechnology Company Details

Table 99. Minhai Biotechnology Business Overview

Table 100. Minhai Biotechnology Vaccine Product

Table 101. Minhai Biotechnology Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 102. Minhai Biotechnology Recent Development

Table 103. Mitsubishi Tanabe Pharma Company Details

Table 104. Mitsubishi Tanabe Pharma Business Overview

Table 105. Mitsubishi Tanabe Pharma Vaccine Product

Table 106. Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 107. Mitsubishi Tanabe Pharma Recent Development

Table 108. Moderna Therapeutics Company Details

Table 109. Moderna Therapeutics Business Overview

Table 110. Moderna Therapeutics Vaccine Product

Table 111. Moderna Therapeutics Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 112. Moderna Therapeutics Recent Development

Table 113. Mylan Company Details

Table 114. Mylan Business Overview

Table 115. Mylan Vaccine Product

Table 116. Mylan Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 117. Mylan Recent Development

Table 118. Plumbline Life Sciences Company Details

Table 119. Plumbline Life Sciences Business Overview

Table 120. Plumbline Life Sciences Vaccine Product

Table 121. Plumbline Life Sciences Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 122. Plumbline Life Sciences Recent Development

Table 123. Sanofi Company Details

Table 124. Sanofi Business Overview

Table 125. Sanofi Vaccine Product

Table 126. Sanofi Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 127. Sanofi Recent Development

Table 128. Translate Bio Company Details

Table 129. Translate Bio Business Overview

Table 130. Translate Bio Vaccine Product

Table 131. Translate Bio Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 132. Translate Bio Recent Development

Table 133. Walvax Biotechnology Company Details

Table 134. Walvax Biotechnology Business Overview

Table 135. Walvax Biotechnology Vaccine Product

Table 136. Walvax Biotechnology Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 137. Walvax Biotechnology Recent Development

Table 138. Wuhan Institute of Biological Products Company Details

Table 139. Wuhan Institute of Biological Products Business Overview

Table 140. Wuhan Institute of Biological Products Vaccine Product

Table 141. Wuhan Institute of Biological Products Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 142. Wuhan Institute of Biological Products Recent Development

Table 143. Zoties Company Details

Table 144. Zoties Business Overview

Table 145. Zoties Vaccine Product

Table 146. Zoties Revenue in Vaccine Business (2020-2025) & (US$ Million)

Table 147. Zoties Recent Development

Table 148. Vaccine Market Trends

Table 149. Vaccine Market Drivers

Table 150. Vaccine Market Challenges

Table 151. Vaccine Market Restraints

Table 152. Research Programs/Design for This Report

Table 153. Key Data Information from Secondary Sources

Table 154. Key Data Information from Primary Sources

List of Figures

Figure 1. Vaccine Product Picture

Figure 2. Global Vaccine Market Share by Type: 2024 VS 2031

Figure 3. Varicella Vaccine Features

Figure 4. Influenza Vaccine Features

Figure 5. Polio Vaccine Features

Figure 6. Hepatitis A Vaccine Features

Figure 7. Rabies Vaccine Features

Figure 8. BCG Vaccine Features

Figure 9. Hepatitis B Features

Figure 10. Pertussis, Diphtheria, Tetanus Features

Figure 11. Pneumococcal Features

Figure 12. Global Vaccine Market Share by Application: 2024 VS 2031

Figure 13. For Adult

Figure 14. For Child

Figure 15. Vaccine Report Years Considered

Figure 16. Global Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Vaccine Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Europe Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. China Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Japan Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. Global Vaccine Market Share by Players in 2024

Figure 24. Global Top Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine as of 2024)

Figure 25. The Top 10 and 5 Players Market Share by Vaccine Revenue in 2024

Figure 26. North America Vaccine Market Share by Type (2020-2025)

Figure 27. North America Vaccine Market Share by Application (2020-2025)

Figure 28. Europe Vaccine Market Share by Type (2020-2025)

Figure 29. Europe Vaccine Market Share by Application (2020-2025)

Figure 30. China Vaccine Market Share by Type (2020-2025)

Figure 31. China Vaccine Market Share by Application (2020-2025)

Figure 32. Japan Vaccine Market Share by Type (2020-2025)

Figure 33. Japan Vaccine Market Share by Application (2020-2025)

Figure 34. AstraZeneca Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 35. BioNTech Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 36. Boehringer-Ingelheim Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 37. CCBIO Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 38. CSL Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 39. CureVac Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 40. Elanco Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 41. GSK Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 42. Hulan Bio Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 43. Indian Immunologicals Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 44. Merck Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 45. Minhai Biotechnology Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 46. Mitsubishi Tanabe Pharma Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 47. Moderna Therapeutics Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 48. Mylan Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 49. Plumbline Life Sciences Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 50. Sanofi Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 51. Translate Bio Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 52. Walvax Biotechnology Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 53. Wuhan Institute of Biological Products Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 54. Zoties Revenue Growth Rate in Vaccine Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Vaccines for the Elderly Market Research Report 2024

Global Multiple Vaccine Market Research Report 2024

Global Seasonal Vaccines Market Research Report 2024

Global HIV Vaccine Market Research Report 2025

Global Consumption Type Vaccine Market Research Report 2024

Global Vaccine Management Software Market Research Report 2025

Global Adult and Pediatric Vaccines Market Research Report 2024

Global Vaccination Device Market Research Report 2024

Vaccine Container Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Vaccine Adjuvants Market

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Commercial Fish Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV and AIDS Vaccine Market Research Report 2024

Global Norovirus Vaccine Market Research Report 2024

Global Biopharmaceutical and Vaccines Market Research Report 2024

Global Electric Vaccine Vehicle Market Research Report 2025

Vaccine Refrigerant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccine Management Solution Market Research Report 2024

Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions